10x Genomics Inc. (NASDAQ: TXG) announced the acquisition of Proteintech Genomics, a division within Proteintech Group that develops high-plex proteomic ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE